Prise en charge du mélanome

Caroline Robert; Andrea Cavalcanti; Fréd́eric Kolb; Benjamin Sarfati; Antoine Moya-Plana; Gorana Tomasic; Christina Mateus

Prise en charge du mélanome

Translated title of the contribution: Management of patients with melanoma

Caroline Robert, Andrea Cavalcanti, Fréd́eric Kolb, Benjamin Sarfati, Antoine Moya-Plana, Gorana Tomasic, Christina Mateus

Research output: Contribution to journal › Review article › peer-review

Abstract

Management ot patients with metastatic melanoma has been revolutionized over the last tew years with targeted anti-BRAF therapies for BRAF-mutant melanomas (in about 50% of the cases) and immunotherapy with anti-CTLA-4. Several new drugs are now authorized and available. Because of their new mechanisms of action, they also have new adverse events and guidelines concerning their safety are of critical importance. New innovative strategies using combination of targeted therapies and immunotherapies with anti-PD-1 are in accelerated development. The quality of patient-physician relationship is central to this promising but complex new paradigm of treatment.

Translated title of the contribution	Management of patients with melanoma
Original language	French
Pages (from-to)	75-80
Number of pages	6
Journal	Revue du Praticien
Volume	64
Issue number	1
Publication status	Published - 1 Jan 2014

Cite this

@article{8d276929cdd84a889c0b57004babb188,

title = "Prise en charge du m{\'e}lanome",

abstract = "Management ot patients with metastatic melanoma has been revolutionized over the last tew years with targeted anti-BRAF therapies for BRAF-mutant melanomas (in about 50% of the cases) and immunotherapy with anti-CTLA-4. Several new drugs are now authorized and available. Because of their new mechanisms of action, they also have new adverse events and guidelines concerning their safety are of critical importance. New innovative strategies using combination of targeted therapies and immunotherapies with anti-PD-1 are in accelerated development. The quality of patient-physician relationship is central to this promising but complex new paradigm of treatment.",

author = "Caroline Robert and Andrea Cavalcanti and Fr{\'e}{\'d}eric Kolb and Benjamin Sarfati and Antoine Moya-Plana and Gorana Tomasic and Christina Mateus",

year = "2014",

month = jan,

day = "1",

language = "Fran{\c c}ais",

volume = "64",

pages = "75--80",

journal = "Revue du Praticien",

issn = "0035-2640",

number = "1",

}

TY - JOUR

T1 - Prise en charge du mélanome

AU - Robert, Caroline

AU - Cavalcanti, Andrea

AU - Kolb, Fréd́eric

AU - Sarfati, Benjamin

AU - Moya-Plana, Antoine

AU - Tomasic, Gorana

AU - Mateus, Christina

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Management ot patients with metastatic melanoma has been revolutionized over the last tew years with targeted anti-BRAF therapies for BRAF-mutant melanomas (in about 50% of the cases) and immunotherapy with anti-CTLA-4. Several new drugs are now authorized and available. Because of their new mechanisms of action, they also have new adverse events and guidelines concerning their safety are of critical importance. New innovative strategies using combination of targeted therapies and immunotherapies with anti-PD-1 are in accelerated development. The quality of patient-physician relationship is central to this promising but complex new paradigm of treatment.

AB - Management ot patients with metastatic melanoma has been revolutionized over the last tew years with targeted anti-BRAF therapies for BRAF-mutant melanomas (in about 50% of the cases) and immunotherapy with anti-CTLA-4. Several new drugs are now authorized and available. Because of their new mechanisms of action, they also have new adverse events and guidelines concerning their safety are of critical importance. New innovative strategies using combination of targeted therapies and immunotherapies with anti-PD-1 are in accelerated development. The quality of patient-physician relationship is central to this promising but complex new paradigm of treatment.

UR - http://www.scopus.com/inward/record.url?scp=84894148717&partnerID=8YFLogxK

M3 - Article 'review'

C2 - 24649552

AN - SCOPUS:84894148717

SN - 0035-2640

VL - 64

SP - 75

EP - 80

JO - Revue du Praticien

JF - Revue du Praticien

IS - 1

ER -

Prise en charge du mélanome

Abstract

Other files and links

Cite this